Global Advanced Research Journal of Economics, Accounting and Finance (GARJEAF)
March 2013 Vol. 2(2), pp. 039-044
Copyright © 2013 Global Advanced Research Journals


Full Length Research Paper

Profitability Indicators of Listed Pharmaceutical Industries of Bangladesh: A Comparative Study of Square and Beximco Pharmaceutical Companies

Mouri Dey1 and Suman Dey2


1Lecturer Department of Accounting and Information Systems University of Chittagong.

2Lecturer Department of Humanities Chittagong University of Engineering and Technology (CUET)

*Corresponding Author’s Email:

Accepted 06 February, 2013



Pharmaceutical industry is technologically the most advanced manufacturing industry in Bangladesh and the third largest industry in terms of contribution to government’s revenue. The industry contributes about 1% of the total GDP. There are about 250 licensed pharmaceutical companies in Bangladesh. Currently a little over 100 companies are in production. According to IMS, a US-based market research firm, the retail market size is about BDT 84 billion as on 2011. Based on IMS report for the fourth quarter 2011, square pharmaceuticals holds the top market share in the retail market (18.7%), followed by Incepta and Beximco pharma. This sector fulfills 97% of the local medicine requirement. Besides, it is exporting chemicals and pharmaceutical products to global market including European market. The professional think tank, quality management, innovative ideas, government support are the key factors for the development of this sector. Hence the present study reports the profitability of two listed pharmaceutical companies of four year accounting period from 2008 to 2011. The analysis shows that average profitability indicators for Square are higher than Beximco, except gross profit ratio and operating profit ratio. On the other hand, the six other profitability indicators of Square are much higher than that of Beximco and go with the industry norm. Beximco has not been able to attain industry average net profit ratio, return on investment and return on equity, cash flow margin and cash return on assets

Keywords:  Profit, Profitability indicators, Square and Beximco Pharmaceuticals industry.







Related Articles

Original Research Articles
Mohamad HH, Ibrahim AH, Massoud HH
Assessment of the Expected Construction Companys Annual Work Volume Using Neural Network and Multiple Regression Models
Glo. Adv. Res. J. Econ. Account. Finance June 2012 Vol: 1(3): - [Abstract] [Full Text - PDF] (528 KB)
Haji Saediman
Semi Mechanized Brick Making in Southeast Sulawesi Feasibility and Constraints for its Adoption
Glo. Adv. Res. J. Econ. Account. Finance June 2016 Vol: 5(6): - [Abstract] [Full Text - PDF] (273 KB)
Oko, A. E. Ndu and Eboh, F. E
Warranties and marketing liabilities in Nigeria: a study of the food, beverage and tobacco industry
Glo. Adv. Res. J. Econ. Account. Finance May 2013 Vol: 2(5): - [Abstract] [Full Text - PDF] (174 KB)
Wilbert Chagwiza
Liquidity derivatives as solution to Zimbabwean economic liquidity problems
Glo. Adv. Res. J. Econ. Account. Finance April 2013 Vol: 2(3): - [Abstract] [Full Text - PDF] (151 KB)
Tchalim Tom-Irazou
Identifying Opportunities in Togo’s Agriculture: Case of the Savannah Region
Glo. Adv. Res. J. Econ. Account. Finance July 2015 Vol: 4(7): - [Abstract] [Full Text - PDF] (165 KB)
Chaudhury Shripati Mishra, Trinath Taraputia, Benudhara Suchen
Policy Advocacy for Climate Smart Agriculture in Millets: An Initiative for Ensuring Food Security in Tribal Communities of Koraput Tract, Odisha, India
Glo. Adv. Res. J. Econ. Account. Finance July 2014 Vol: 3(7): - [Abstract] [Full Text - PDF] (173 KB)

Current Issue

Viewing Options

View Full Article - PDF
Download Full Article - PDF

Search for Articles

Mouri Dey on Google Scholar
Mouri Dey on Pubmed
Suman Dey on Google Scholar
Suman Dey on Pubmed


Viewed 3620
Printed 772
Downloaded 717
Powered By iPortal Works